Prolgolimab with Chemotherapy as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer by Laktionov, K., Smolin, A., Stroyakovskiy, D., Moiseenko, V., Dvorkin, M., Andabekov, T., Cheng, Y., Liu, B., Kozlov, V., Odintsova, S., Dvoretsky, S., Mochalova, A., Urda, M., Yi, T., Li, X., László, U., Müller, V., Bogos, K., Fadeeva, N., Musaev, G., Liu, Q., Kirtbaya, D., Shi, J., Gladkov, O., Narimanov, M., Semiglazova, T., Khasanova, A., Chovanec, J., Andrašina, I., Szabová, A., Rosinská, O., Sudekova, D., Zsolt, P-S., Ran, F., Sun, M., Jiang, O., Chen, R., Zhao, E., Liu, C., Tan, W., Pirmagomedov, A., Poddubskaya, E., Kislov, N., Shumskaya, I., Sorokina, I., Zinkina-Orikhan, A., Linkova, Yu, Fogt, S., Liaptseva, D., Siliutina, A., Basova, O., Kryukov, F.

Get full text

Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Control... by Mazurov, V. I., Nasonov, E. L., Lila, A. M., Korolev, M. A., Prystrom, A. M., Kundzer, E. V., Soroka, N. F., Kastanayan, A. A., Povarova, T. V., Plaksina, T. V., Antipova, O. V., Krechikova, D. G., Smakotina, S. A., Tciupa, O. A., Puntus, E. V., Raskina, T. A., Shilova, L. N., Kropotina, T. V., Nesmeyanova, O. B., Popova, T. A., Vinogradova, I. B., Dokukina, E. A., Plotnikova, A. V., Pukhtinskaia, P. S., Zinkina-Orikhan, A. V., Linkova, Yu. N., Eremeeva, A. V., Lutckii, A. A.

Get full text

A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Interferon β-1a Formulations for S.C. Administration in Patients with Remitting Multiple Sclerosis: Fi... by Boiko, A. N., Bosenko, L. P., Vasilovskii, V. V., Volkova, L. I., Zakharova, M. N., Kotov, S. V., Lekomtseva, E. V., Negrich, T. I., Parshina, E. V., Patrusheva, O. P., Prokopenko, S. V., Sazonov, D. V., Timchenko, P. V., Trinitatskii, Yu. V., Khabirov, F. A., Khavunka, M. Ya, Chichanovskaya, L. V., Sherman, M. A., Lin’kova, Yu. N., Zinkina-Orikhan, A. V., Tursunova, K. B.

Get full text

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled pha... by Lomakin, Nikita V., Bakirov, Bulat A., Protsenko, Denis N., Mazurov, Vadim I., Musaev, Gaziyavdibir H., Moiseeva, Olga M., Pasechnik, Elena S., Popov, Vladimir V., Smolyarchuk, Elena A., Gordeev, Ivan G., Gilyarov, Mikhail Yu, Fomina, Darya S., Seleznev, Anton I., Linkova, Yulia N., Dokukina, Ekaterina A., Eremeeva, Anna V., Pukhtinskaia, Polina S., Morozova, Maria A., Zinkina-Orikhan, Arina V., Lutckii, Anton A.

Get full text

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo... by Puig, Luís, Bakulev, Andrey L., Kokhan, Muza M., Samtsov, Alexey V., Khairutdinov, Vladislav R., Morozova, Maria A., Zolkin, Nikita A., Kuryshev, Ivan V., Petrov, Alexey N., Artemeva, Antonina V., Zinkina-Orikhan, Arina V.

Get full text

A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic... by Demidov, Lev, Kharkevich, Galina, Petenko, Natalia, Moiseenko, Vladimir, Protsenko, Svetlana, Semiglazova, Tatiana, Zimina, Anastasia, Kovalenko, Nadezhda, Fadeeva, Natalia, Kirtbaya, Dmitry, Belogortsev, Igor, Tantsyrev, Denis, Odintsova, Svetlana, Nesterova, Alfia, Vorontsova, Karina, Makarycheva, Yulia, Linkova, Yulia, Zinkina-Orikhan, Arina, Siliutina, Anna, Sorokina, Irina, Liaptseva, Daria, Chistyakov, Vladimir, Lutsky, Anton

Get full text

New Anti-Cd20 Divozilimab in Relapsing Multiple Sclerosis: Phase III MIRANTIBUS Trial Results by Boyko, Alexey, Linkova, Yulia, Zinkina-Orikhan, Arina, Porozova, Anastasia

Get full text